Feb 22 (Reuters) - Drug developer Novavax Inc said on Monday it has completed patient enrollment in the late-stage study of its COVID-19 vaccine in the United States and Mexico. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)
我们的标准: 汤森路透“信任原则”